ISRCTN46751362已完成不适用
A European randomised multicentre study of interferon alpha-2b versus no treatment after intensive therapy and Autologous hematopoeitic Stem Cell Transplantation (ASCT) for relapsing lymphoma patients
Schering-Plough Ltd (UK)0 个研究点目标入组 0 人开始时间: 2002年8月19日最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •1. Patients with histologically proven non-Hodgkin's lymphoma or Hodgkin's disease, in first relapse or first progression responding to salvage regimen, and treated with high dose therapy and ASCT
- •2. Normal renal and hepatic function.
- •3. Eastern Cooperative Oncology Group (ECOG) performance status zero to three
- •4. Aged 18 to 65 years
- •5. No history of prior or concomitant malignancy except for treated (surgery or radiotherapy) basal cell carcinoma of the skin or carcinoma in situ, whatever the site
排除标准
- •Not provided at time of registration
研究者
相似试验
已完成
不适用
European multicentre randomised controlled clinical trial: Heavy Silicone Oil (HSO) versus standard silicone oil as long term vitreous tamponadeRetinal detachment, proliferative vitreoretinopathyEye DiseasesOther retinal disordersISRCTN47399029Rotterdam Eye Hospital (Oogziekenhuis Rotterdam) (The Netherlands)80
尚未招募
不适用
European multi centre trial to compare the effectiveness of two different phototherapy narrow band UVB protocols in vitiligowhite spot disease10035023vitiligoNL-OMON32305Academisch Medisch Centrum20
招募中
不适用
Multicenter European prospective study on the efficacy and safety of the Focal C2 CryoBalloon Ablation System in patients with Barrett*s Esophagus-related neoplasiaNL-OMON50590Sint Antonius Ziekenhuis42
招募中
不适用
Efficacy and safety of focal cryoballoon ablation for patients with dysplastic Barrett's esophagusNL-OMON25207St. Antonius Hospital, Nieuwegein107
终止
2 期
A Study Evaluating Lanreotide as Maintenance Therapy in Patients With Non-Resectable Duodeno-Pancreatic Neuroendocrine Tumors (REMINET)Metastatic/Locally Advanced, Non-resectable, Duodeno-pancreatic Neuroendocrine TumoursNCT02288377Federation Francophone de Cancerologie Digestive53